Will Mike Lustgarten start to regularly ANY of {rapamycin, metformin, acarbose, SGLT2 inhibitors) by the end of 2027? | Manifold Markets

Will Mike Lustgarten start to regularly ANY of {rapamycin, metformin, acarbose, SGLT2 inhibitors) by the end of 2027?

40%

chance

40%

chance

AlexKChen

Apr 28, 2028

M$0 bet

Place your bet

Amount

M$

Probability

40%→40%

Payout if YES

M$0(+0.0%)